All PlansAdministrativeLow impact
Drug recall: Voluntary Nationwide Recall: Tydemy (Lupin July)
UPMC Health Plan·OB-GYN, Family Medicine, General Practice·Provider Notice
We identified it
Aug 7, 2026
Summary
Lupin Pharmaceuticals has issued a voluntary nationwide recall of two lots of Tydemy (a contraceptive/prenatal vitamin combination) due to failed stability testing that could reduce product effectiveness and result in unintended pregnancy. Billing teams should be aware that affected patients may seek alternative contraceptive products, and providers should verify lot numbers before dispensing.
Action Required
Immediately: Notify providers and clinical staff of the Tydemy recall. Front desk and pharmacy staff should verify patient prescriptions to identify if any affected lots were dispensed. For affected patients, coordinate with providers to offer alternative contraceptive options. No billing system changes are required, but track any patient contacts or follow-up visits related to recall notification for documentation purposes. Refer patients to FDA recall information at https://www.upmchealthplan.com/providers/medical/announcements-updates/announcements/2023-announcements/09-08-drug-recall-voluntary-nationwide-recall-tydemy.